New cosmetic use of a glycoprotein extract from Prunus dulcis
The glycoprotein extract from Prunus dulcis addresses pollution-induced skin and hair issues by regulating bacterial flora and enhancing radiance and homogeneity, providing a natural and effective cosmetic solution.
Patent Information
- Application Number
- FR2020012127
- Authority / Receiving Office
- FR · FR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-11-25
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2039-04-02
AI Technical Summary
Existing cosmetic solutions fail to effectively maintain and increase the radiance and homogeneity of skin complexion and hair shine while addressing the negative effects of pollution and microbial imbalance, such as redness, blackheads, and excess sebum.
A glycoprotein extract from Prunus dulcis (sweet almond) is used topically or orally to regulate commensal bacterial flora, reduce pollution effects, and enhance skin and hair radiance and homogeneity, while being non-irritating and chemically stable.
The glycoprotein extract effectively maintains and increases skin and hair radiance, reduces redness and blackheads, and combats pollution-induced skin issues by enhancing commensal bacterial strains, thereby improving skin and hair appearance.
Abstract
Description
Title of the invention: New cosmetic use of a glycoprotein extract of Prunus dulcis Technical field
[0001] The present invention relates to the cosmetic use of a glycoprotein extract of the Prunus dulcis plant for maintaining and / or increasing the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes and / or the radiance of the skin appendages, advantageously the hair. Prior art
[0002] Environmental pollution is one of the extrinsic factors, in addition to ultraviolet rays and unfavorable climatic conditions, which has a major impact on human skin and its appendages, particularly hair and mucous membranes. This pollution leads to the deposition of fine particles and harmful or even toxic molecules, responsible for a reduction in the radiance and / or uniformity of skin tone, but also the shine and / or luster of hair. Pollution thus results, for example, in dull skin and uneven skin tone, dull hair and mucous membranes.
[0003] In addition, the above extrinsic factors will potentially disrupt the microbial flora present on the surface of the skin and scalp. The consequences at the skin level can manifest themselves in particular by the appearance of redness, comedones, or even excess sebum and induce a greasy or shiny appearance of the skin. The skin complexion thus loses its homogeneity.
[0004] There is thus a need in the fields of cosmetics and dermatology for alternative natural active ingredients, capable of maintaining and / or increasing and / or the radiance and homogeneity of the complexion of the skin and / or mucous membranes but also the radiance of the skin appendages, in particular the hair, in particular when the skin, mucous membranes and / or appendages are exposed to pollution and / or their microbial flora is unbalanced, in particular under the effect of pollution.
[0005] The applicant has surprisingly and unexpectedly discovered that a glycoprotein extract of the plant P. dulcis has the property of maintaining and / or increasing the brightness of the skin appendages, advantageously the hair, and / or the brightness and / or homogeneity of the complexion of the skin and / or the mucous membranes.
[0006] The applicant has further discovered that a glycoprotein extract of the plant P. dulcis prevents the appearance and / or reduces the unsightly and / or uncomfortable manifestations of the skin and / or skin appendages induced by an imbalance and / or a reduction in the commensal cutaneous and / or mucosal bacterial flora and / or induced by pollution, such as redness of the skin and / or mucous membranes, and / or comedones, and / or excess sebum, and / or a shiny appearance of the skin and / or skin appendages.
[0007] Prunus dulcis, better known as sweet almond or P. amygdalus var. dulcis, is a fruit tree of the Rosaceae family of the genus Amygdalus L.
[0008] Prunus dulcis contains seeds known for their richness in fatty acids, particularly oleic and linoleic acid. They are also rich in proteins. The oil from the seeds of P. dulcis has been known since antiquity for its softening, moisturizing and toning properties.
[0009] Application GB240578 describes a cosmetic composition comprising sweet almond oil for improving skin radiance. Application FR3012963 also describes a composition comprising sweet almond oil for lightening the complexion.
[0010] Application CN103027859 further discloses a cosmetic composition comprising sweet almond oil comprising Ganoderma capense glycopeptides, for improving skin dryness, for lightening the skin and for an anti-wrinkle effect.
[0011] Application CN106350320 describes a cosmetic composition for improving radiance and reducing dark spots, comprising sweet almond oil.
[0012] Furthermore, a glycoprotein extract of sweet almond has been described for its properties on lipolysis in application FR2879099.
[0013] Finally, a glycoprotein extract of P. dulcis is already marketed under the name Dulcemine™ by the applicant as an active ingredient for moisturizing and repairing skin and hair.
[0014] However, it has never been disclosed or suggested that a glycoprotein extract of P. dulcis has properties for improving the brightness of skin appendages, advantageously hair, nor the brightness and / or homogeneity of skin tone and / or mucous membranes. Nor has it been disclosed or suggested that a glycoprotein extract of P. dulcis has properties for reducing redness of the skin and / or mucous membranes, nor for reducing comedones or the shiny appearance of the skin and / or skin appendages. Summary of the invention
[0015] The extract according to the invention has the advantage of being a topically acceptable active ingredient which does not irritate the skin or skin appendages and which has great chemical stability. It does not cause allergies. In addition to its properties on the radiance and / or homogeneity of skin tone and the shine of hair, this extract has the advantage of regulating the commensal cutaneous bacterial flora. It has the added advantage of combating the harmful effects of pollution.
[0016] This extract can be produced on an industrial scale.
[0017] A first subject of the invention thus relates to the cosmetic, non-therapeutic use of a glycoprotein extract of the plant P. dulcis to maintain and / or increase the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes, and / or the radiance of the cutaneous appendages, advantageously the hair.
[0018] Another subject concerns the non-therapeutic cosmetic use of said extract in a cosmetic composition comprising at least one cosmetically acceptable excipient.
[0019] A 3rd object relates to a cosmetic care process comprising the topical or oral administration of the extract according to the invention or of a cosmetic composition comprising it.
[0020] A final object concerns a glycoprotein extract of P. dulcis for its pharmaceutical use, advantageously dermatological, to prevent the appearance and / or reduce acne and / or eczema and / or atopic dermatitis. Detailed description
[0021] A first object of the invention therefore concerns the cosmetic, non-therapeutic use of a glycoprotein extract of the plant P. dulcis to maintain and / or increase the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes, the radiance of the cutaneous appendages, advantageously the hair.
[0022] The term "cosmetic use" means a non-therapeutic use, i.e. a non-pharmaceutical or non-dermatological use, i.e. a use intended for all or part of healthy skin and / or mucous membrane and / or cutaneous appendage.
[0023] The term "healthy skin or mucous membrane or skin appendage" means skin or mucous membrane or skin appendage which does not require therapeutic treatment, which does not present infection, scar, disease, inflammation or skin condition such as candidiasis, impetigo, psoriasis, eczema, acne or dermatitis, or wound, injury and / or other dermatosis.
[0024] “Skin” means any part of the body and / or face, including the scalp.
[0025] The term “annexes” means nails, body hair, hair, eyelashes, eyebrows, advantageously hair.
[0026] The term “mucosa” means the nasal and / or buccal and / or gingival and / or labial and / or vaginal and / or anal mucosa, preferably the labial mucosa.
[0027] The extract according to the invention can be administered orally or topically. Preferably, it is applied topically. The extract according to the invention is a to- acceptable sting.
[0028] The term "topically acceptable" here means an extract that is non-irritating to the skin or skin appendages, non-toxic and does not induce an allergic reaction.
[0029] The term "topical application" means the direct application of the extract or of a cosmetic composition comprising it to the skin and / or skin appendages, or its vaporization on the surface of the skin and / or mucous membranes and / or skin appendages, preferably hair.
[0030] In one embodiment of the invention, the cosmetic use of the extract according to the invention comprises its topical application or that of a cosmetic composition comprising it on all or part of the body and / or the face chosen from the legs, feet, armpits, hands, thighs, stomach, décolleté, neck, arms, torso, back, labial mucosa, face, advantageously the face, and / or cutaneous appendages, advantageously the hair.
[0031] Thus, in a first embodiment, the glycoprotein extract of P. dulcis according to the invention makes it possible to maintain and / or increase the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes and / or the radiance of the cutaneous appendages, advantageously the hair.
[0032] In an advantageous embodiment of the invention, the extract maintains and / or increases the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes and / or the radiance of the cutaneous appendages, advantageously the hair, by maintaining and / or increasing the cutaneous and / or mucosal commensal flora.
[0033] Here, the term “maintaining and / or increasing the cutaneous and / or mucosal commensal flora” means maintaining and / or increasing the quantity of beneficial commensal bacterial strains at the level of the skin and / or mucous membranes.
[0034] The term "shine of the skin appendages" means the shine of said appendages. Advantageously, this is the shine of the hair.
[0035] The term "maintaining and / or improving the radiance of the complexion" means preventing the loss of and / or increasing the radiance and / or shine of the complexion and / or preventing and / or reducing dull complexion, in particular due to an unbalanced microbial balance, in particular a reduction in the number of beneficial commensal bacterial strains and / or excess sebum and / or due to pollution, in particular due to fine polluting particles and / or UVA rays.
[0036] Advantageously, the maintenance and / or improvement of the radiance of the complexion is thus obtained by maintaining and / or increasing the cutaneous and / or mucosal commensal flora, in particular when this cutaneous and / or mucosal commensal flora is reduced.
[0037] The measurement of the radiance of the complexion and the homogeneity of the skin tone can for example be carried out in vivo, in particular by chromametry or by image analysis. This last in vivo measurement method consists of taking high-resolution photographs in crossed polarized configuration of the face of volunteers taken at 45° before and after application of the tested product. Based on these digital photographs, an image analysis allows the extraction and quantification of specific parameters (for example: L*, a*, b*, C, h°) related to the color, brightness, homogeneity, and texture of the skin.
[0038] The term "maintaining and / or improving the homogeneity of the complexion" means preventing and / or reducing imperfections and / or irregularities in the color of the complexion such as redness, comedones and / or visible pores, the shiny appearance of the skin and / or skin appendages and / or excess sebum.
[0039] The term "beneficial commensal bacterial strain" means a bacterial strain which does not induce pathology and / or infection and / or inflammation and / or skin condition such as candidiasis, impetigo, psoriasis, eczema, acne or dermatitis, or wound, injury and / or other dermatosis.
[0040] Preferably, the beneficial commensal bacterial strain is chosen from S. hominis, S. wameri, S. capitis, Acinetobacter Iwolffii or their combinations, advantageously S. epidermidis and / or S. hominis.
[0041] “Beneficial commensal bacterial flora” means a population of beneficial commensal bacterial strains.
[0042] An increase in the quantity of beneficial commensal bacterial strains can help prevent and / or reduce the occurrence and / or quantity of harmful bacterial strains such as Propionibacterium acnes, and / or pathogens, including Staphylococcus aureus. This is referred to as a balanced microbial balance.
[0043] Thus, maintaining and / or increasing the quantity of at least one beneficial commensal bacterial strain chosen from S. hominis, S. wameri, S. capitis, Acinetobacter Iwolffii or combinations thereof, advantageously S. epidermidis and / or S. hominis, makes it possible to prevent the appearance of and / or reduce the unsightly and / or uncomfortable manifestations of the skin and / or mucous membranes and / or cutaneous appendages induced by this imbalance in the microbial balance, in particular redness of the skin and / or mucous membranes, comedones, the shiny appearance of the skin and / or cutaneous appendages and / or excess sebum.
[0044] In a particularly advantageous embodiment of the invention, the extract is not used for the treatment of so-called sensitive skin. Here, the term "sensitive skin" means skin that is in particular dehydrated and / or weakened, without being considered pathological. Very advantageously, the cosmetic use of the glycoprotein extract of P. dulcis is intended for normal skin.
[0045] The present invention is particularly suitable for the care and / or cosmetic treatment of normal skin and / or skin with an imbalance in the microbiome balance. crobian, particularly a decrease in the number of beneficial commensal bacterial strains.
[0046] In an advantageous embodiment, the extract according to the invention is in an effective quantity to maintain and / or increase the quantity of S. epidermidis, when this quantity is increased by at least 2%, advantageously by at least 7%, still advantageously by at least 11% in the presence of the extract according to the invention, in comparison with the quantity measured in the absence of the extract, preferably under the conditions described in example 2.
[0047] In an advantageous embodiment, the measurement of the quantity of S. epidermidis is carried out by measuring the optical density at 600 nm after a period of 24 hours of incubation of said strain in a suitable culture medium in the presence of the extract according to the invention at a concentration by weight of 0.4% relative to the final volume of the culture medium. Advantageously, the extract is the glycoprotein extract of P. dulcis seeds as prepared according to example 1a). Still advantageously, the strain of S. epidermidis is the strain ATCC12228.
[0048] In another advantageous embodiment, the extract according to the invention is in an effective quantity for "preventing the appearance and / or reducing redness of the skin and / or mucous membranes, and / or excess sebum, and / or a shiny appearance of the skin and / or skin appendages, and / or comedones" when it maintains and / or increases the quantity of S. hominis by at least 4%, advantageously by at least 7%, still advantageously by at least 11%, in comparison with the quantity measured in the absence of the extract, under the conditions described in Example 2.
[0049] Preferably, the measurement of the quantity of S. hominis is carried out by measuring the optical density at 600 nm after a period of 24 hours of incubation of said strain in a suitable culture medium in the presence of the extract according to the invention at a concentration by weight of 0.1% relative to the final volume of the culture medium. Advantageously, the extract is the glycoprotein extract of P. dulcis seeds as prepared according to example 1a). Still advantageously, the strain of S. hominis is the strain ATCC27844.
[0050] In yet another advantageous embodiment, the extract according to the invention is in an effective quantity to "prevent the appearance and / or reduce comedones" when it reduces the quantity of Propionibacterium acnes on the surface of the skin, by at least 1.5%, preferably by at least 2%, even more preferably by at least 4% in the presence of the extract according to the invention, in comparison with the quantity of P. acnes measured without said extract.
[0051] Preferably according to the invention, the measurement of the quantity of P. acnes is carried out by measuring the optical density at 600 nm after a period of 24 hours of incubation of said strain in an appropriate culture medium in the presence of the extract according to the invention at a final concentration by weight of 0.4% relative to the final volume of the culture medium. Advantageously, the reduction in the quantity of P. acnes is measured at the level of the face. Still advantageously, the extract according to the invention is the glycoprotein extract of P. dulcis seeds as prepared according to example 1a).
[0052] The extract according to the invention is therefore useful for preventing the appearance and / or reducing redness of the skin and / or mucous membranes, and / or excess sebum, and / or a shiny appearance of the skin and / or skin appendages, and / or comedones.
[0053] In another advantageous embodiment of the invention, the extract maintains and / or increases the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes, and / or the radiance of the cutaneous appendages, advantageously the hair, by reducing the percentage of adhesion of fine polluting particles to the surface of the skin and / or mucous membranes and / or cutaneous appendages, and / or by increasing the synthesis of ATP measured after exposure to UVA and / or fine polluting particles, and / or by reducing the cellular cytotoxicity advantageously induced by fine polluting particles and / or UVA.
[0054] According to an advantageous embodiment, the extract according to the invention reduces the percentage of adhesion of fine polluting particles by at least 11%, measured at the skin level after deposition of said fine particles, in the presence of a cream comprising the extract according to the invention, in comparison with the percentage of adhesion of said polluting particles measured without said cream.
[0055] Preferably, this measurement of the percentage of adhesion is carried out after deposition of iron oxide microparticles modeling the fine particles with a diameter equal to 2.5 μm, at the level of the antero-internal face of the forearm of a population of 21 women of Caucasian origin aged from 19 to 45 years, still advantageously after application of a cream comprising a final concentration by weight of the extract according to the invention of 0.25% relative to the total weight of the cream. Preferably, the extract used included in the cream is the glycoprotein extract of P. dulcis seeds as prepared under the conditions described in example 1a).
[0056] Alternatively, the measurement of the percentage of adhesion of the iron oxide microparticles is carried out after washing with water on the antero-internal face of the forearm of a population of 21 women of Caucasian origin aged from 19 to 45 years, again advantageously after application of a cream comprising a final concentration by weight of the extract according to the invention of 0.25% relative to the total weight of the cream. Preferably, the extract used included in the cream is the glycoprotein extract of P. dulcis seeds as prepared under the conditions described in example 1a).
[0057] Still preferably, the adhesion and cleaning of the microparticles are evaluated by image acquisition and analysis after deposition of the microparticles and after rinsing with water. The areas studied are visualized using a video microscope equipped with a x20 fiber optic mobile objective, coupled with a computer image acquisition system. The surface covered by the fine particles is measured by image analysis, under the conditions described in Example 5 (Table 5).
[0058] In another advantageous embodiment, the extract according to the invention reduces cellular cytotoxicity, advantageously induced by polluting fine particles and UVA by increasing the cell viability measured in human cells by at least 20% in comparison with the level of cell viability measured when said cells are subjected to a combination of UVA and polluting fine particles and without extract.
[0059] Preferably, the measurement of cell viability is carried out in human keratinocytes, again advantageously in the presence of the glycoprotein extract of P. dulcis seeds as prepared according to example 1a), as described under the conditions of example 3.
[0060] In yet another advantageous embodiment of the invention, the extract according to the invention increases the synthesis of ATP measured after exposure of the cells under combination of UVA and polluting fine particles, by at least 8%, still advantageously by at least 20%, very advantageously by at least 30% in comparison with the level of ATP synthesis measured under identical conditions but without extract. Preferably, the synthesis of ATP is measured in human keratinocytes, preferentially of the HaCaT line. Advantageously, the glycoprotein extract of P. dulcis is the glycoprotein extract of seeds as prepared under the conditions described in example 1a). Still advantageously, the measurement of the synthesis of ATP is carried out by bioluminescence, under the conditions described in example 4.
[0061] Thus, the glycoprotein extract of P. dulcis increases ATP synthesis and / or decreases cellular cytotoxicity, in particular that induced by UVA and / or fine polluting particles, advantageously induced by the combination of UVA and fine polluting particles.
[0062] The glycoprotein extract of P. dulcis according to the invention is an extract of all or part of the P. dulcis plant chosen from the leaves, stems, flowers, fruits, branches, roots and / or seeds. Advantageously, it is a seed extract. The term "seed extract" here means an extract of any part of the plant comprising seeds, in particular any part of the fruit comprising them, and advantageously, it is an extract containing only seeds.
[0063] P. dulcis extract is a glycoprotein extract. The term "glycoprotein extract" means a protein extract of the P. dulcis plant obtained from the dried flour seeds of P. dulcis and comprising glycosylated proteins. This flour has been defatted. Advantageously, it contains less than 10% by weight of lipid relative to the total weight of the dry matter, very advantageously, it does not contain lipid. Thus, the glycoprotein extract according to the invention is not an extract of P. dulcis oil, particularly not an extract of seed oil. Advantageously, the glycoprotein extract comprises at least: - glycosylated proteins with a molecular weight of between 250kDa and 330kDa, advantageously between 260kDa and 320kDa, more advantageously between 270kDa and 310kDa, still advantageously between 280kDa and 300kDa, very advantageously 290kDa. Preferably, these glycosylated proteins are referred to as amandoglobulins. Advantageously, these proteins are linked by covalent bonding to oligosaccharides, still advantageously sucrose. - glycosylated proteins with a molecular weight of between 130kDa and 170kDa, advantageously between 140kDa and 160kDa, and even more advantageously 150kDa. Preferably, these glycosylated proteins are referred to as amandoalbumins. Advantageously, these proteins are linked by covalent bonding to oligosaccharides, even more advantageously sucrose. - And an emulsin-type enzyme complex with phosphatase and beta-glucosidase activities.
[0064] In the context of the invention, the molecular weight of the proteins is determined by high performance liquid chromatography.
[0065] Preferably, the glycoprotein extract of P. dulcis according to the invention essentially contains only glycosylated proteins with a molecular weight of between 280kDa and 300kDa, advantageously 290kDa, and glycosylated proteins with a molecular weight of between 140kDa and 160kDa, advantageously 150kDa, and the emulsin-type enzyme complex having phosphatase and [3-glucosidase] activities.
[0066] Very preferably, the glycoprotein extract of P. dulcis according to the invention consists only of glycosylated proteins with a molecular weight of between 280kDa and 300kDa, advantageously 290kDa, and glycosylated proteins with a molecular weight of between 140kDa and 160kDa, advantageously 150kDa, and the emulsin-type enzyme complex having phosphatase and [3-glucosidase] activities.
[0067] The extract according to the invention can be obtained by different extraction methods known to those skilled in the art, chosen from maceration, hot decoction, by grinding including ultrasonic grinding, using a mixer, or the extract can be obtained by extraction in water under subcritical or supercritical conditions (carbon dioxide). Preferably, the extraction is carried out by maceration.
[0068] The protein extraction is carried out from defatted flour, therefore from dry matter, in an amount of 1% to 30% by weight, advantageously from 5% to 20%, very advantageously from 5% to 15%, still advantageously from 10%, by weight relative to the total weight of the defatted flour and the extraction solvent.
[0069] The protein extraction is carried out over a period of 30 minutes to 24 hours, preferably 30 minutes to 12 hours, more preferably over a period of 1 hour to 5 hours, and more advantageously over a period of 1 hour to 2 hours. Very advantageously, the protein extraction is carried out over a period of 1 hour.
[0070] The glycoprotein extract according to the invention is obtained by extraction of the proteins in a solvent or solvent mixture, preferably a polar protic solvent, and advantageously in water, an alcohol, a glycol, a polyol, a water / alcohol, water / glycol or water / polyol mixture (such as water mixed with ethanol, glycerol and / or butylene glycol and / or other glycols such as xylitol and / or propanediol, etc.) from 99 / 1 to 1 / 99 (weight / weight), advantageously in water as the sole solvent.
[0071] In particular, the extract is obtained by aqueous extraction. For the purposes of the present invention, the term "extract obtained by aqueous extraction" means any extract obtained by extraction with an aqueous solution containing more than 60% by weight, advantageously at least 70% by weight, in particular at least 80% by weight, more particularly at least 90% by weight, in particular at least 95% by weight, of water relative to the total weight of the aqueous solution, even more advantageously not containing glycol and in particular not containing alcohol, more particularly containing only water.
[0072] Advantageously, the solvent may comprise sodium chloride, preferably at a final concentration by weight of between 0.5% and 1.5%, still preferably at a concentration by weight of 0.9% relative to the total weight of the solvent comprising sodium chloride.
[0073] The extraction is carried out at a temperature between 4°C and 90°C, advantageously between 50°C and 80°C, still advantageously between 65°C and 75°C, very advantageously at 72°C.
[0074] The protein extraction is carried out at a pH between 5.0 and 7.0, advantageously between 5.5 and 6.5, and even more advantageously it is carried out at a pH of 6.1.
[0075] In a first advantageous embodiment of the invention, the glycoprotein extract of P. dulcis is prepared from 10% by weight of dried seed flour. The glycoprotein extract is then obtained by aqueous extraction of the proteins at pH 6.1, at a temperature of 72°C, for a period of 1 hour, in water as the sole solvent comprising sodium chloride at a final concentration by weight of 0.9% relative to the total weight of the solvent comprising sodium chloride. The liquid extract obtained is then separated by centrifugation, filtered and then a clarification step is carried out. The extract thus clarified is then concentrated, filtered and then atomized under the conditions as described in example 1a).
[0076] In a second embodiment of the invention, the glycoprotein extract of P. dulcis is prepared from 10% by weight of dried seed flour. The glycoprotein extract is then obtained by aqueous extraction of the proteins at pH 6.5, at a temperature of 65°C, for a period of 2 hours, in water as the sole solvent comprising sodium chloride at a final concentration by weight of 1.2% relative to the total weight of the solvent comprising sodium chloride. The liquid extract obtained is then separated by centrifugation, filtered and then a clarification step is carried out. The extract thus clarified is then concentrated, filtered and then atomized in the presence of maltodextrins at a concentration by weight of 80% relative to the total weight of the atomized extract, under the conditions described in example 1b).
[0077] In a 3rd embodiment, the glycoprotein extract of P. dulcis is prepared from 15% by weight of dried seed flour. The glycoprotein extract is then obtained by aqueous extraction of the proteins at pH 6.5, at a temperature of 65°C, for a period of 2 hours, in water as the sole solvent comprising sodium chloride at a final concentration by weight of 1.2% relative to the total weight of the solvent comprising sodium chloride. The liquid extract obtained is then separated by centrifugation, filtered and then a clarification step is carried out. The extract thus clarified is then concentrated and then filtered under the conditions described in example 1c).
[0078] The extract according to the invention is used alone or in a cosmetic or dermatological composition.
[0079] When used alone in the form of a cosmetic ingredient, it is preferably solubilized in an aqueous solution containing glycerin, advantageously present at a concentration of 60% to 90%, still advantageously of 70% to 85%, very advantageously at a concentration of 80% by weight relative to the total weight of the aqueous solution comprising the extract.
[0080] In an alternative embodiment of the invention, the extract is solubilized and / or diluted in a solvent, in particular a polar solvent, such as water, an alcohol, a polyol, a glycol, such as pentylene glycol and / or butylene glycol and / or hexylene glycol and / or caprylyl glycol, or one of their mixtures, preferably a hydroglycolic mixture, still preferably containing a glycol chosen from hexylene glycol, caprylyl glycol and their mixtures. Advantageously, the extract obtained is diluted and / or soluble in an aqueous solution containing hexylene glycol, in particular containing between 0.1 and 10% by weight of hexylene glycol, preferably between 0.5 and 5% by weight of hexylene glycol, relative to the total weight of the cosmetic ingredient. Advantageously, the extract obtained is diluted and / or soluble in an aqueous solution containing caprylyl glycol, in particular containing between 0.01 and 5% by weight of caprylyl glycol, preferably between 0.1 and 1% by weight of caprylyl glycol, relative to the total weight of the aqueous solution comprising the extract.
[0081] In particular, the aqueous solution in which the glycoprotein extract of P. dulcis according to the invention is solubilized comprises xanthan gum, in particular between 0.01 and 5% by weight of xanthan gum relative to the total weight of the aqueous solution, more particularly between 0.1 and 1% by weight of xanthan gum relative to the total weight of the aqueous solution comprising the extract.
[0082] Advantageously, the solution in which the glycoprotein extract of P. dulcis according to the invention is solubilized comprises hexylene glycol, caprylyl glycol and xanthan gum.
[0083] In another alternative embodiment, the liquid extract obtained according to the invention is atomized in the presence of maltodextrin, in a concentration of 70% by weight to 90% by weight relative to the total weight of the maltodextrin and the extract, advantageously from 75% to 85%, and even more advantageously at a concentration of 80% by weight of maltodextrin relative to the total weight of the maltodextrin and the extract. The extract is in powder form.
[0084] Another subject relates to the use of a glycoprotein extract of P. dulcis in a cosmetic composition comprising at least one cosmetically acceptable excipient for maintaining and / or increasing the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes, and / or the radiance of the cutaneous appendages, advantageously the hair.
[0085] The cosmetic composition according to the invention is useful for preventing the appearance and / or reducing unsightly and / or uncomfortable manifestations of the skin and / or mucous membranes and / or cutaneous appendages induced by an imbalance and / or a reduction in the commensal cutaneous and / or mucosal bacterial flora, advantageously redness of the skin and / or mucous membranes, and / or excess sebum, and / or comedones, and / or a shiny appearance of the skin. The cosmetic composition comprising the extract according to the invention is also useful for combating the harmful effects of pollution.
[0086] Thus, the cosmetic composition makes it possible to maintain and / or increase the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes and / or the radiance of the skin appendages, advantageously the hair.
[0087] In one embodiment of the invention, the glycoprotein extract of P. dulcis is used in the composition in the form of an aqueous or oily solution, rinsing or not, an aqueous cream or gel or an oily gel, in particular a shower gel, a milk, an emulsion, a microemulsion or a nanoemulsion, in particular oil-in-water or water-in-oil or multiple or silicone, a mask, a serum, a lotion, a liquid soap, a dermatological bar, an ointment, a mousse, a patch, an anhydrous product, preferably liquid, pasty or solid, a hair care lotion, a shampoo, a conditioner.
[0088] Said composition can be applied topically or administered orally. Advantageously, it will be applied topically. In a preferred embodiment, the cosmetic composition comprises at least one cosmetically acceptable excipient.
[0089] Thus advantageously, the extract according to the invention is present in the composition, advantageously cosmetic, at a concentration of 1x10 4% to 10%, preferably of 1x10 3% to 5%, and even more preferably of 1x10 2% to 3% by weight, relative to the total weight of the composition.
[0090] The excipient(s) used in the cosmetic composition are chosen from surfactants and / or emulsifiers, preservatives, buffering agents, chelating agents, denaturants, opacifying agents, pH adjusters, reducing agents, stabilizing agents, thickeners, gelling agents, film-forming polymers, fillers, matting agents, glossing agents, pigments, colorants, perfumes, and mixtures thereof. The CTFA (Cosmetic Ingredient Handbook, Second Edition (1992)) describes various cosmetic excipients suitable for use in the present invention.
[0091] Advantageously, the excipient(s) are chosen from the group comprising polyglycerols, esters, cellulose polymers and derivatives, lanolin derivatives, phospholipids, lactoferrins, lactoperoxidases, sucrose-based stabilizers, vitamin E and its derivatives, xanthan gums, natural and synthetic waxes, vegetable oils, triglycerides, unsaponifiables, phytosterols, silicones, protein hydrolysates, betaines, aminoxides, plant extracts, sucrose esters, titanium dioxides, glycines, and parabens, and more preferably from the group consisting of steareth-2, steareth-21, glycol-15 stearyl ether, cetearyl alcohol, phenoxyethanol, methylparaben, ethylparaben, propylparaben, butylparaben, butylene glycol, caprylyl glycol, natural tocopherols, glycerin, dihydroxycetyl sodium phosphate,isopropyl hydroxycetyl ether, glycol stearate, triisononanoin, octyl cocoate, polyacrylamide, isoparaffin, laureth-7, carbomer, propylene glycol, hexylene glycol, glycerol, bisabolol, dimethicone, sodium hydroxide, PEG 30-dipolyhydroxysterate, capric / caprylic triglycerides, cetearyl octanoate, dibutyl adipate, grape seed oil, jojoba oil, magnesium sulfate, EDTA, cyclomethicone, xanthan gum, citric acid, sodium lauryl sulfate, mineral waxes and oils, isostearyl isostearate, propylene glycol dipelargonate, propylene glycol isostearate, PEG 8, beeswax, hydrogenated palm heart oil glycerides, lanolin oil, sesame oil, cetyl lactate, lanolin alcohol, castor oil, titanium dioxide, lactose, sucrose, low density polyethylene, isotonic saline, and mixtures thereof.
[0092] The cosmetic composition may also comprise other ingredients having the same properties and inducing a synergistic effect or not with the extract according to the invention, or ingredient agents with complementary effects. The extract may be combined with any plant extract having similar properties of preventing the appearance and / or reducing imperfections in the skin tone and / or increasing the radiance of the complexion, in particular an extract of the mushroom Inonotus obliquas marketed by the applicant, an extract of Argania spinosa oil marketed under the name Arganyl™, an extract of Moringa oleifera seeds marketed under the name Purisoft™ by the applicant, a combination of an extract of Salvia miltiorrhiza and niacinamide marketed under the name CollRepair™ by the applicant, an extract of Achillea millefolium marketed under the name Neurobiox™ by the applicant,an extract of Cassia alata leaves marketed under the name DN-Age™ and / or a lychee extract marketed under the name Litchiderm™ as antioxidant active ingredients, a chicory extract marketed under the name Lox-Age™, an extract of Polygonum bistorta marketed under the name Perlaura™, a galangal extract marketed under the name Hyalufix™, a corn extract marketed under the name Deliner™ or an extract of Voandzeia subterranea marketed under the name Epigenist™ by the applicant or active ingredients promoting skin firmness such as a synthetic tetrapeptide marketed under the name Dermican™, an extract of Hibiscus abelmoschus marketed under the name Linefactor™, a purified pea extract marketed under the name Proteasyl™,an extract of Manilkara multinervis marketed under the name Elestan™ by the applicant. An extract of the plant Origanum majorana marketed under the name Dermagenist™ and / or an extract of Khaya senegalensis marketed under the name Collalift®18 and / or an extract of Eperua falcata marketed under the name Eperuline™ or an extract comprising phytosterols, in particular [3-sitosterol and / or campesterol and / or brassicasterol from rapeseed oil and marketed by the applicant under the name Phytosoothe™, may also be added to the cosmetic composition.
[0093] Other active ingredients, particularly for the hydration of the skin and / or mucous membranes, may be combined with the glycoprotein extract according to the invention. Thus, among the active ingredients that are moisturizing and / or active on the barrier function and / or that increase the water content of the skin and / or mucous membranes and / or stimulate the synthesis of aquaporin to improve the circulation of water in the cells, mention may be made of serine, urea and its derivatives, products such as microspheres of marine collagen and chondroitin sulfate as glycosaminoglycan, a formulation comprising a hyaluronic acid salt, urea, trehalose, glycerol triacetate and polyquaternium respectively marketed under the names Marine Filling sphères™ and Advanced moisturizing complex™, hyaluronic acid microspheres marketed under the name Hyaluronic Filling Spheres™, a red algae extract or a mixture of acacia polysaccharide, alginate and serine respectively marketed under the names Osmogelline™ and Micropatch™ Serine, or a combination of pullulan,of hyaluronic acid or one of its salts or one of its derivatives and of alginic acid, one of its salts or one of its derivatives, marketed under the name PatcH20™. ,
[0094] Another subject of the invention also relates to a cosmetic care method comprising the topical or oral administration, advantageously the topical application, of a glycoprotein extract of P. dulcis or of a cosmetic composition comprising it, to maintain and / or increase the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes, and / or the radiance of the cutaneous appendages, advantageously of the hair, advantageously by preventing the appearance and / or reducing the unsightly and / or uncomfortable manifestations of the skin and / or mucous membranes and / or cutaneous appendages induced by an imbalance and / or a decrease of at least one beneficial cutaneous and / or mucosal commensal bacterial strain, advantageously chosen from S. hominis, S. wameri, S. capitis, Acinetobacter Iwolffii or combinations thereof, advantageously S. epidermidis and / or S. hominis.Advantageously, these manifestations are redness of the skin and / or mucous membranes, and / or excess sebum, and / or comedones, and / or a shiny appearance of the skin.
[0095] In one embodiment, the cosmetic care method comprises the application of the glycoprotein extract of P. dulcis or of a cosmetic composition comprising it, topically, to all or part of the body and / or the face chosen from the legs, feet, armpits, hands, thighs, stomach, décolleté, neck, arms, torso, back, face, advantageously the face, and / or the mucous membranes, advantageously the labial mucosa, and / or the cutaneous appendages, advantageously the hair.
[0096] A final object concerns a glycoprotein extract of P. dulcis for its pharmaceutical use, advantageously dermatological, to prevent the appearance and / or reduce acne and / or eczema and / or atopic dermatitis.
[0097] In one embodiment of the invention, the glycoprotein extract of P. dulcis is included in a pharmaceutical composition, advantageously dermatological, which comprises at least one dermatologically acceptable excipient.
[0098] Advantageously, the glycoprotein extract of P. dulcis is included in the pharmaceutical composition, advantageously dermatological, at a concentration by weight of 1x10 4% to 10%, preferably of 1x10 3% to 5%, and even more preferably of 1x10 2% to 3% by weight, relative to the total weight of the pharmaceutical composition, advantageously dermatological.
[0099] Examples refer to the description of the invention and are presented below. These examples are given for illustration purposes and do not limit the scope of the invention. The examples are an integral part of the present invention and any feature appearing new over any prior art from the description taken as a whole, including the examples, is an integral part of the invention. In the examples and unless otherwise indicated, the temperature is expressed in degrees Celsius. Examples
[0100] Example 1: Methods of preparing the P. dulcis extract according to the invention
[0101] Example 1a): The glycoprotein extract of P. dulcis seeds is prepared from 10% by weight of dried seed flour. The glycoprotein extract is then obtained by aqueous extraction of the proteins at pH 6.1, at a temperature of 72°C, for a period of 1 hour, in water as the sole solvent comprising sodium chloride at a final concentration by weight of 0.9% relative to the total weight of the solvent comprising sodium chloride. The liquid extract obtained is then separated by centrifugation, filtered and then a clarification step is carried out. The extract thus clarified is then concentrated, filtered and then atomized.
[0102] Example 1b): The glycoprotein extract of P. dulcis seeds is prepared from 10% by weight of dried seed flour. The glycoprotein extract is then obtained by aqueous extraction of the proteins at pH 6.5, at a temperature of 65°C, for a period of 2 hours, in water as the sole solvent comprising sodium chloride at a final concentration by weight of 1.2% relative to the total weight of the solvent comprising sodium chloride. The liquid extract obtained is then separated by centrifugation, filtered and then a clarification step is carried out. The extract thus clarified is then concentrated, filtered and then atomized in the presence of maltodextrins (80% w / w).
[0103] Example 1c): The glycoprotein extract of P. dulcis seeds is prepared from 15% by weight of dried seed flour. The glycoprotein extract is then obtained by aqueous extraction of proteins at pH 6.1, at a temperature of 72°C, for a period of 1 hour, in water as the sole solvent comprising sodium chloride at a final concentration by weight of 0.9% relative to the total weight of the solvent comprising sodium chloride. The liquid extract obtained is then separated by centrifugation, filtered and then a clarification step is carried out. The extract thus clarified is then concentrated and then filtered. It is in liquid form. Example 2: Increase in commensal bacterial flora
[0104] Protocol: The glycoprotein extract of P. dulcis as described in example 1a), was diluted in a bacterial culture medium (Trypto Casein Soy, TSA) at a final concentration by weight of 0.1% and 0.4% (for S. hominis and S. epidermidis respectively) relative to the final volume of the culture medium. The media comprising the ingredients were then incubated for a period of 24 hours at a temperature of 35°C aerobically in the presence of a calibrated inoculum of 5.4x105 of S. epidermidis (ATCC 12228) and 1.75x105 for S. hominis (ATCC 27844).
[0105] The quantity of bacteria was calculated by measuring the optical density at 600 nm after a 24-hour incubation period (n = 3). The results are expressed as the mean (AVG) of the 3 trials in each test (SD: standard deviation).
[0106] Results:
[0107] [Tableauxl] S. hominis AVG SD Control (no treatment) 0.434 0.020 P. dulcis glycoprotein extract Example 1a) 0.1% (w / v) 0.510 0.014
[0108] [Tables2] S. epidermidis AVG SD Control (no treatment) 0.576 0.01 P. dulcis glycoprotein extract Example 1a) 0.4% (w / v) 0.713 0.012
[0109] Conclusion: The glycoprotein extract of P. dulcis seeds has shown its ability to increase the quantity of S. epidermidis and S. hominis, making it possible to strengthen the commensal cutaneous bacterial flora. The extract makes it possible to prevent the appearance and / or reduce redness and / or comedones and / or excess sebum and / or the shiny appearance of the skin and to maintain and / or increase the brightness of the cutaneous appendages, advantageously the hair, as well as the brightness and / or homogeneity of the complexion of the skin and / or mucous membranes. Example 3: Inhibition of pollution-induced cytotoxicity on keratinocytes
[0110] Protocol: Human keratinocytes were seeded in a culture medium containing fetal calf serum, and incubated at 37°C (5% CO2 and 95% relative humidity) for a period of 3 days in order to obtain a saturated cell lawn. The culture medium was then replaced with a Hanks balanced salt solution comprising pollution particles (2.5 pm) and the glycoprotein extract of P. dulcis prepared under the conditions described in example 1a) at a final concentration by weight of 0.2% relative to the total volume of the medium and then incubated at 37°C for a period of 1 day. The cultures were irradiated with UVA (20 J / cm2). After irradiation, the cell culture medium was renewed and the cells were incubated for a period of 2 days at 37°C. Cell viability was measured (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide test or MTT).After incubation of keratinocytes with MTT for a period of 3 hours, the cell mat was dissolved in DMSO. The optical density was measured at 550 nm by spectroscopy, to measure the quantity of living cells (cell viability). The results are expressed as an average percentage compared to the control of cells irradiated under UVA in the absence of fine particles.
[0111] The statistical test was carried out using the ANOVA method.
[0112] Results:
[0113] [Tables3] AVG Control (UVA) 144* Pollution (UVA + fine particles 25pg / mL) 100 Pollution (UVA + fine particles 25pg / mL) and glycoprotein extract P. dulcis Example 1a) 0.2% (w / v) 128*
[0114] *P<0.001
[0115] Conclusion: The glycoprotein extract of P. dulcis made it possible to reduce the cytotoxicity induced by the combination of UVA and fine particles and made it possible to maintain and / or increase the brightness of the skin appendages, advantageously the hair, as well as the brightness and / or homogeneity of the skin tone and / or mucous membranes. Example 4: Inhibition of ATP degradation in the presence of the extract according to the invention
[0116] Protocol: Human keratinocytes were seeded in a culture medium containing fetal calf serum, and incubated at 37°C (5% CO2 and 95% relative humidity) for a period of 3 days. The culture medium was replaced for a Hanks' balanced salt solution including pollution particles, the glycoprotein extract of P. dulcis at a final concentration by weight of 0.2% relative to the total volume of the medium and as prepared in example 1a), then the medium was incubated for a period of 1 day at 37°C. The cultures were then irradiated under UVA (20J / cm2). After irradiation, the cell culture medium was renewed and the cells incubated for a period of 2 days at 37°C. Cellular energy was measured by enzymatic measurement of the ATP produced by the cells (ATP Bioluminescence kit CLSnl 1699695001 / Roche diagnostic France).
[0117] The results are expressed as mean percentage + / - standard deviation compared to the control (cells irradiated under UVA in the absence of fine particles). The statistical test was carried out according to the ANOVA method.
[0118] Results'.
[0119] [T ables 4] AVERAGE AND Control (UVA) 119* 2 Pollution (UVA + fine particles 25pg / mL) 100 2 Pollution (UVA + fine particles 25pg / mL) and glycoprotein extract P. dulcis Example 1a) 0.2% (w / v) 120* 10
[0120] *P<0.01
[0121] Conclusion: The glycoprotein extract of P. dulcis made it possible to reduce the decrease in ATP synthesis induced by the combination of UVA and fine particles by at least 8%, showing its capacity to maintain and / or increase the brightness of the skin appendages, advantageously the hair, as well as the brightness and / or homogeneity of the skin tone and / or mucous membranes. Example 5: In vivo measurement of the reduction in adhesion of fine particles to the skin in the presence of the extract according to the invention.
[0122] Protocol: A cream comprising a final concentration by weight of the extract according to the invention of 0.25% relative to the total weight of the cream (Formulation example 6), or without said extract replaced by water, was applied to the antero-internal face of the forearm of a population of 21 women of Caucasian origin aged 19 to 45 years after deposition of iron oxide microparticles modeling fine particles of 2.5 pm in diameter.
[0123] The tested extract included in the cream was the glycoprotein extract of P. dulcis seeds as prepared under the conditions described in Example 1a). The adhesion and cleaning of the microparticles were evaluated by image acquisition and analysis after deposition of the microparticles and after rinsing with water 24 hours after application of the cream. The areas studied were visualized using a video microscope equipped with a 20x mobile fiber optic objective, coupled with a computer image acquisition system. The surface area covered by the fine particles was measured by image analysis. Table 5 shows the average percentage of adhesion of microparticles to the skin of the test population.
[0124] Results:
[0125] [Tables5] Percentage of fine particle adhesion after deposition AVG Untreated area 100 Cream comprising water, without extract (Negative control) 99 Cream comprising P. dulcis seed glycoprotein extract 0.25% (w / w) (Ex. la) 88* Percentage of fine particle adhesion after washing with water AVG Untreated area 100 Cream comprising water, without extract (Control) 92 Cream comprising P. dulcis seed glycoprotein extract 0.25% (w / w) (Ex. la) 75**
[0126] *p= 0.006; **p<0.001 (Student test)
[0127] Conclusion: the application of the cream comprising the glycoprotein extract of P. dulcis seeds made it possible to reduce the adhesion of fine polluting particles before and after washing by 11% and 17% respectively compared to the control cream.
[0128] These results show the beneficial effect of the extract on maintaining and / or increasing the radiance of the skin appendages, advantageously the hair, as well as the radiance and / or homogeneity of the complexion of the skin and / or mucous membranes. Example 6: Examples of cosmetic formulations comprising the glycoprotein extract of P. dulcis
[0129] Example 6a) Formulation for the body and / or face
[0130] A cosmetic product in the form of a face cream may have a composition by weight, consisting of the following aqueous and fatty phases. The percentages are expressed by weight relative to the total weight of the composition.
[0131] [Tableauxô] Fatty phase Isostearyl Diglyceryl Succinate 3.00 Paraffin oil 15.00 Quatemium-18 Hectorite 0.50 Poly(PEG-22 / Dodecyl Glycol) 1.00 Aqueous phase Magnesium sulfate 0.80 Butylene glycol 4.00 P. dulcis glycoprotein extract (according to ex. la) 1.00 Distilled water 9.00 Methylparaben, hexamidine diisethionate, 2-Bromo-2 nitropropane-1,3-diol and propylparaben (Elestab 4112) 0.35 Perfume 0.30 Distilled water Qsp 100.00
[0132] Example 6b) Formulation for the face (Cream)
[0133] A cosmetic product in the form of a cream for the body and / or face may, for example, have a composition by weight, consisting of the following aqueous and fatty phases, as indicated below.
[0134] [Tables?] Fatty phase Ceteareth 25 2.00 Ceteareth 6 (and) Stearyl Stearyl alcohol 1.00 Cetyl alcohol 4.00 Glycerol stearate 4.00 Petrolatum 5.00 Caprylic / capric triglycerides 5.00 Aqueous phase Glycerin 10.00 Glycoprotein extract of P. dulcis (prepared according to T ex. la) 1.50 Distilled water 8.50 Methylparaben, hexamidine diisethionate, 2-Bromo-2 nitropropane-1,3-diol and propylparaben (Elestab 4112) 0.40 Perfume 0.30 Distilled water Qsp 100.00
[0135] The process for preparing the face cream essentially consists of heating the fatty phase to 80°C, heating the aqueous phase also to 80°C and dissolving Elestab 4112 (Methylparaben, hexamidine diisethionate, 2-Bromo-2 ni-tropropane-1,3-diol and propylparaben) therein, separately preparing the stock solution of P. dulcis glycoprotein extract, pouring the fatty phase into the aqueous phase with turbine stirring, then, at around 50°C, introducing the stock solution of P. dulcis extract and continuing stirring until cooling.
Claims
Claims
1. Non-therapeutic cosmetic use of a glycoprotein extract of Prunus dulcis seeds for maintaining and / or increasing the radiance and / or homogeneity of the complexion of healthy skin and / or healthy mucous membranes.
2. Use according to claim 1 such that the glycoprotein extract of P. dulcis prevents the appearance and / or reduces redness of healthy skin and / or healthy mucous membranes, and / or comedones, and / or a shiny appearance of healthy skin.
3. Use according to any one of claims 1 or 2, such that the glycoprotein extract of P. dulcis comprises glycoproteins with a molecular weight of between 260kDa and 320kDa, advantageously between 280kDa and 300kDa, still advantageously 290kDa.
4. Use according to any one of claims 1 to 3 such that the glycoprotein extract of P. dulcis comprises glycoproteins with a molecular weight of between 130kDa and 170kDa, advantageously between 140kDa and 160kDa, still advantageously 150kDa.
5. Use according to any one of claims 1 to 4 such that the glycoprotein extract is obtained from defatted flour of P. dulcis seeds.
6. Use according to any one of claims 1 to 5 such that the extract maintains and / or increases the quantity of at least one beneficial commensal bacterial strain, advantageously Staphylococcus epidermidis and / or Staphylococcus hominis.
7. Use according to any one of claims 1 to 6 such that the extract increases ATP synthesis and / or decreases cellular cytotoxicity.
8. Use according to any one of claims 1 to 7 such that the extract is included in a cosmetic composition comprising at least one acceptable cosmetic excipient, at a concentration by weight of 1x10 4% to 10%, preferably of 1x10 3% to 5%, relative to the total weight of the cosmetic composition.
9. Use according to claim 8 such that the cosmetic composition is in the form of an aqueous or oily solution, rinsing or not, a cream or an aqueous gel or an oily gel, in particular a shower gel, a milk, an emulsion, a microemulsion or a nanoemulsion, in particular oil-in-water or water-in-oil or multiple or silicone, a mask, a serum, a lotion, a liquid soap, a bar dermatological, an ointment, a mousse, a patch, an anhydrous product, preferably liquid, pasty or solid, a hair care lotion, a shampoo, a conditioner.
10. Cosmetic care method comprising the topical or oral administration, advantageously the topical application, of a glycoprotein extract of P. dulcis seeds or of a composition comprising it to maintain and / or increase the radiance and / or homogeneity of the complexion of healthy skin and / or healthy mucous membranes.
11. Cosmetic care method according to claim 10 in which the extract prevents the appearance and / or reduces the unsightly and / or uncomfortable manifestations of healthy skin and / or healthy mucous membranes induced by an imbalance and / or a decrease in at least one beneficial commensal cutaneous and / or mucosal bacterial strain, advantageously redness of healthy skin and / or healthy mucous membranes, and / or comedones, and / or a shiny appearance of healthy skin.
12. Cosmetic care method according to claim 10 such that the glycoprotein extract of P. dulcis seeds or the cosmetic composition comprising it is applied to all or part of the body and / or face chosen from the legs, feet, armpits, hands, thighs, stomach, décolleté, neck, arms, torso, back, face, advantageously the face, and / or mucous membranes, advantageously the labial mucosa.
13. Glycoprotein extract of P. dulcis seeds for its pharmaceutical use, advantageously dermatological, for preventing the appearance and / or reducing acne and / or eczema and / or atopic dermatitis.
14. Extract for use according to claim 13 as defined in any one of claims 3 to 5.
